Recent News About Hesperos and Human-on-a-Chip Technology

Discussion of Human-on-a-chip for Rare Diseases

By Hesperos | November 30, 2019 | 0 Comments

In our latest publication, UCF & Hesperos researchers discuss how Human-on-a-chip systems can be used to address the unique challenges facing rare diseases. Researchers cite that rare diseases are “limited by the high cost of research … Read More


By Hesperos | September 30, 2019 | 0 Comments

We are proud to announce our latest papers has been featured on the director’s blog of the The National Institutes of Health. In the post, Dr. Francis Collins discusses a study in which Hesperos created a … Read More

Hesperos Human-on-a-Chip Technology Awarded First Phase of $3.8 Million Milestone-based NIH Grant to Study Opiate Overdoses in Collaboration With UCF

By Hesperos | September 26, 2019 | 0 Comments

Hesperos, Inc., ( announced today the University of Central Florida (UCF) received the first phase of a $3.8 million milestone-based National Institutes of Health (NIH) grant for research involving the company’s human-on-a-chip system. “We are grateful … Read More

First Time Human-on-a-Chip Predicts In Vivo Results Based on In Vitro Model

By Hesperos | July 3, 2019 | 0 Comments

Hesperos’ integrated heart-liver Human-on-a-Chip® shown to correctly determine cardiotoxic mechanisms preclinically and replicate results seen in in vivo studies (ORLANDO, Fla.) — Hesperos Inc., pioneers of the “human-on-a-chip” in vitro system has announced the use of its innovative multi-organ model to successfully measure the … Read More

Human-on-a-chip Model Enables Simultaneous Testing of Cancer Drug Efficacy and Off-Target Toxicity to Enable Determination of Therapeutic Index

By Hesperos | June 19, 2019 | 0 Comments

In vitro multi-organ system by Hesperos, Inc. realistically replicates the responses of cancer treatments and has potential to inform treatment decisions. ORLANDO, FLA – June 19, 2019 — A reconfigurable “body-on-a-chip” model could transform drug development … Read More

Hesperos’ Models Under Consideration to Address Opiod Crisis

By Hesperos | March 18, 2019 | 0 Comments

The interest in our human-on-a-chip model continues to grow.  Last week we brought our systems to the National Center for Translational Science (NCATS) at the NIH in Washington, D.C. to perform a real-time demo using live … Read More

Mice no more? Hesperos’ multi-organ “Human-on-a-Chip” System Found Effective for Long-Term Toxicology Testing

By Hesperos | March 1, 2019 | 0 Comments
lab tests

Collaboration between L’Oreal, Hesperos and UCF results in further reduction in reliance on animal testing in drug and cosmetics development (ORLANDO, Fla.) The replacement of animals as test subjects is one step closer to reality with … Read More